Background Recurrent stroke is a frequent, disabling event after ischemic stroke. This study
compared the efficacy and safety of two antiplatelet regimens — aspirin plus extended-…

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted, focusing on 2006 through October 2012 and …

Background The contribution of various risk factors to the burden of stroke worldwide is
unknown, particularly in countries of low and middle income. We aimed to establish the …

The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …

Despite the global impact and advances in understanding the pathophysiology of cerebrovascular
diseases, the term “stroke” is not consistently defined in clinical practice, in clinical …

Background Although stroke is the second leading cause of death worldwide, no
comprehensive and comparable assessment of incidence, prevalence, mortality, disability, and …

The aim of this new statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …

Importance Understanding the major health problems in the United States and how they are
changing over time is critical for informing national health policy. Objectives To measure the …

Stroke remains the second-leading cause of death and the third-leading cause of death and
disability combined (as expressed by disability-adjusted life-years lost – DALYs) in the world…

(ACCF) guidelines on secondary prevention, 1 important evidence from clinical trials has
emerged that further supports and broadens the merits of intensive risk-reduction therapies for …